Miguel Gallardo, PhD^1*, Hun Ju Lee, MD^2*, Xiaorui Zhang, BS^1*, Carlos E. Bueso-Ramos, MD³, Laura Pageon^4*, Mark McArthur^5*, Asha Multani^6*, Aziz Nazha, MD⁷, Taghi Manshouri, PhD^8*, Jan Parker-Thornburg^6*, Peter Hu^9*, Yuan Qi^10*, Xiaoping Su, PhD^11*, Inmaculada Rapado^12*, Alfonso Quintás-Cardama^13*, Steven M. Kornblau, MD¹⁴, Joaquin Martinez-López, MD.PhD^15* and Sean M. Post, PhD¹

¹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston
⁴Department of Pathology, MD Anderson Cancer Center, Houston, TX
⁵Department of Pathology, MD Anderson Cancer Center, Houston
⁶Department of Genetics, MD Anderson Cancer Center, Houston
⁷Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁸Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁹School of Health Professions, MD Anderson Cancer Center, Houston
¹⁰Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX
¹¹Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX
¹²Hospital-12-de-Octubre, Madrid, Spain
¹³Department of Leukemia, MD Anderson Cancer Center, Houston
¹⁴The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
¹⁵Hematology, Hospital 12 de Octubre, Madrid, Spain

Sun Mi Park, PhD¹, Angela Thornton, PhD^2*, Ly P. Vu, PhD^1*, Sagar Chhangawala^3*, Gerard Minuesa, PhD^1*, Trevor Barlowe, BA^1*, James Taggart, BS^1*, Patrick Tivnan, BS^1*, Theodore Kim^1*, Ethan Shevach, MD^2*, Christina S Leslie, PhD^3* and Michael G. Kharas, PhD¹

¹Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY
²NIAID, National Institutes of Health, Bethesda, MD
³Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Sara E. Meyer, PhD¹, Emily Orr^1*, Andrew M. Rogers, MS, MD^2*, John G Doench, PhD^3*, Bruce J. Aronow, Ph.D.^4*, Ashish Lal, PhD^5*, Edwina McGlinn, PhD^6* and H. Leighton Grimes, PhD¹

¹Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
²Division of Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
³Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA
⁴Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁵Molecular Genetics Branch, National Cancer Institute, Bethesda, MD
⁶European Molecular Biology Laboratory, Clayton, Victoria, Australia

Joydeep Ghosh, MSc¹, Anindya Chatterjee, MS, PhD^2*, Baskar Ramdas, Ph.D.^3*, Michihiro Kobayashi, MD, PhD^4*, Peilin Ma, MD, PhD^5*, Yan Liu, PhD⁴, David Plas, PhD^6* and Reuben Kapur, Ph.D.²

¹Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN
²Indiana University School of Medicine, Indianapolis, IN
³Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN
⁴Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN
⁵Pediatrics, Indiana University School of Medicine, Herman B Wells Center for Pediatric Research, Indianapolis, IN
⁶University of Cincinnati, Cincinnati, OH

Yana Pikman, MD¹, Alexandre Puissant, PhD^2*, Gabriela Alexe, PhD^3*, Andrew Furman, BA^3*, Stacey Frumm, BA⁴, Linda Ross, PhD^3*, Liying Chen, PhD^3*, Nina Fenouille, PhD^5*, Christopher F. Bassil, BA^3*, Caroline A Lewis, PhD^5*, Richard M. Stone, MD⁶, Daniel J. DeAngelo, MD, PhD⁷, Ilene Galinsky, ANP⁷, Andrew L Kung, MD, PhD⁸, Matthew Vader Heiden, MD, PhD^5*, Michael T. Hemann, PhD^5*, Versha Banerji, MD⁹ and Kimberly Stegmaier, MD¹

¹Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
²Department of Pediatric Oncology, Dana-Farber Cancer Instituté, Boston, MA
³Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴UCSF, San Francisco, CA
⁵Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA
⁶Hematologic Oncology, Dana Farber Cancer Institute, Boston, MA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, NY
⁹Research Institute of Oncology and Hematology, Cancer Care Manitoba, Winnipeg, MB, Canada

Daniela Di Marcantonio, PhD¹, Jessica Vadaketh^1*, Esteban Martinez^1*, Prisco Mirandola, PhD^2*, Giuliana Gobbi, PhD^2*, Michael D. Milsom, PhD^3,4, Claudia Scholl⁵, Stefan Fröhling⁵, Marco Vitale, MD^2* and Stephen Matthew Sykes, PhD¹

¹Fox Chase Cancer Center, Philadelphia, PA
²Biomedical, Biotechnological and Translational Sciences, University of Parma, Parma, Italy
³Experimental Hematology, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany
⁴German Cancer Research Center (DKFZ), Heidelberg, Germany
⁵National Center for Tumor Diseases, Heidelberg, Germany